April 16, 2018
FDA alert: Coastal Meds recalls all sterile products
Editor's Note
The Food and Drug Administration (FDA) on April 13 announced the recall by Coastal Meds (Biloxi, Mississippi) of all nonexpired products marketed as sterile because of visible particles in some of the drug vials for injection and poor sterile production practices.
The FDA on April 5 requested the company inform the public, but they have not done so. Therefore, the FDA is alerting healthcare professionals to dispose of and not administer sterile drugs intended for injection that were produced by Costal Meds.
Free Daily News
- Healthcare’s “Blockbuster Moment:” Dr Dan Weberg to deliver opening keynote address at OR Manager Conference
- Hospital staffing report: Nurse turnover eases but vacancies, costs remain high
- Study: Bariatric surgery beats lifestyle changes for patients with cirrhosis, obesity
- CMS vision shifts as agency halts funding for state programs
- Low-cost blood test predicts cardiovascular event risk
- Hospital M&A activity drops to historic low amid economic and policy uncertainty
- GAO urges HHS to improve drug shortage response coordination
- Study: US maternal mortality rises 28% in 5 years, inequities persist
- Routine preop tests catch hidden risks in outpatient cosmetic surgery, Canadian study finds
- Study: Hospital same‑day knee replacements match ASC outcomes, even in higher‑risk patients
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement